Trials / Completed
CompletedNCT00757627
Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)
Patient-reported Outcomes With Etoricoxib in Real Life
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect disease burden of OA and the effectiveness and patient satisfaction of treatment by Etoricoxib in the normal practice setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etoricoxib | etoricoxib 60 mg QD for 4 weeks. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-09-23
- Last updated
- 2022-02-09
- Results posted
- 2010-05-11
Source: ClinicalTrials.gov record NCT00757627. Inclusion in this directory is not an endorsement.